Table 2.
Univariate for OS |
Multivariate for OS | Univariate for DFS |
Multivariate for DFS | |||
---|---|---|---|---|---|---|
Factors | P | HR (95% CI) | P | P | HR (95% CI) | P |
CT-CD3(H/L) | 0.005 | 0.026 (0.050–0.685) | 0.012 | 0.006 | 0.217 (0.067–0.700) | 0.011 |
IM-CD3(H/L) | 0.091 | 0.242 (0.065–0.899) | 0.034 | 0.027 | 0.188 (0.058–0.617) | 0.006 |
CT-CD4(H/L) | 0.069 | — | 0.261 | 0.192 | — | 0.222 |
IM-CD4(H/L) | 0.002 | 0.029 (0.005–0.187) | 0.001 | 0.011 | 0.077 (0.018–0.329) | 0.001 |
CT-CD8(H/L) | 0.114 | — | 0.320 | 0.083 | — | 0.274 |
IM-CD8(H/L) | 0.770 | — | 0.847 | 0.795 | — | 0.452 |
IS(H/L) | 0.005 | — | 0.121 | 0.007 | 0.098 (0.013–0.755) | 0.026 |
CT-PD-L1 (+/−) | 0.382 | — | 0.439 | 0.245 | — | 0.375 |
IM-PD-L1 (+/−) | 0.688 | — | 0.711 | 0.233 | — | 0.497 |
OS overall survival, DFS disease-free survival, HR hazard ratio, CT center of tumor, IM invasive margin, IS immunoscore